Diabetes: An Old Disease, a New InsightShamim I. Ahmad Diabetes is a complex disease and is also one of the most common. It is very difficult to reach an accurate estimate for the global prevalence of diabetes since the standards and methods of data collection vary widely in different parts of the world. In addition, many potential sufferers are not included in the count because according to an estimate about 50% of cases remain undiagnosed for up to 10 years. However, according to an estimate for 2010, globally, there are about 285 million people (amounting to 6.4% of the adult population) suffering from this disease. This number is estimated to increase to 439 million by 2030 if no cure is found. The general increase in life expectancy, leading to an ageing population, and the global rise in obesity are two main reasons for the increase. With the basic platform set, Editor presents his views and advice to the readers, especially to diabetic patients suffering from T2DM, on the basis of his observations and information collected from other diabetics. |
Contents
CHAPTER 1 INTRODUCTION TO DIABETES MELLITUS | 1 |
CHAPTER 2 CLASSIFICATION OF DIABETES | 12 |
A New Class of Type 1 Diabetes | 20 |
CHAPTER 4 GESTATIONAL DIABETES MELLITUS | 24 |
CHAPTER 5 GLOBAL PREVALENCE AND FUTURE OF DIABETES MELLITUS | 35 |
CHAPTER 6 TYPE 2 DIABETES MELLITUS PANDEMIC IN 21st CENTURY | 42 |
CHAPTER 7 EMERGING TYPE 2 DIABETES IN YOUNG ADULTS | 51 |
CHAPTER 8 IMPAIRMENT OF IMMUNE SYSTEMS IN DIABETES | 62 |
CHAPTER 19 MOLECULAR MECHANISMS OF INSULIN RESISTANCE IN DIABETES | 240 |
CHAPTER 20 VIRAL INFECTIONS AND DIABETES | 252 |
CHAPTER 21 OXIDATIVE STRESS IN DIABETES | 272 |
CHAPTER 22 THE PANCREATIC β CELLS IN HUMANTYPE 2 DIABETES | 288 |
The Lessons of Pancreatic Pathology | 310 |
Nutritional Prevention and Novel Avenues for Therapy | 319 |
CHAPTER 25 CLINICAL FEATURES DIAGNOSTIC CRITERIA AND PATHOGENESIS OF DIABETES MELLITUS | 340 |
CHAPTER 26 MANAGEMENT AND TREATMENT OF DIABETES MELLITUS | 356 |
CHAPTER 9 PERIODONTAL DISEASE AND DIABETES | 76 |
CHAPTER 10 RETINOPATHY IN DIABETES | 88 |
CHAPTER 11 NEPHROPATHY IN DIABETES | 107 |
A Continuing Challenge | 123 |
Oxidative Stress and Macrovascular Complications | 139 |
CHAPTER 14 DIABETIC SOMATIC NEUROPATHY | 155 |
CHAPTER 15 DIABETIC AUTONOMIC NEUROPATHY | 176 |
CHAPTER 16 IMMUNOBIOLOGY OF βCELL DESTRUCTION | 194 |
CHAPTER 17 CARDIOVASCULAR DISEASE AND DIABETES | 219 |
CHAPTER 18 PANCREATIC CANCER AND DIABETES | 229 |
CHAPTER 27 NUTRITIONAL SUPPLEMENTS AND THEIR EFFECT ON GLUCOSE CONTROL | 381 |
CHAPTER 28 HERBAL MEDICINES FOR THE MANAGEMENT OF DIABETES | 396 |
CHAPTER 29 CONTINUOUS SUBCUTANEOUS INSULIN INFUSION CSII PUMPS | 414 |
CHAPTER 30 PANCREATIC TRANSPLANT IN DIABETES | 420 |
CHAPTER 31 WEIGHT REDUCTION IN DIABETES | 438 |
CHAPTER 32 TREATMENT OF OBESE DIABETICS | 459 |
Management and Treatment | 465 |
EPILOGUE AN APPEAL TO THE HEADS OF THE HEALTH SERVICES AND WORLD HEALTH ORGANIZATION WHO | 471 |
| 473 | |
Other editions - View all
Common terms and phrases
activity antibodies antigens apoptosis associated autoantibodies autoimmune autoreactive beta-cell blood glucose cardiovascular disease chronic clinical cytokines decreased diabetes mellitus diabetic foot diabetic neuropathy diabetic patients diabetic retinopathy Diabetologia diagnosis drugs dysfunction effects Endocrinol Metab endothelial Engl enzyme exenatide fatty acids gene genetic glucose levels glucose tolerance glycemic control HbA1c hyperglycemia immune Immunol impaired improved increased incretin induced infection inhibition inhibitors insulin resistance insulin secretion insulin sensitivity insulin signaling islet cell lipid mechanisms Medical metabolic metformin mice muscle NOD mice nondiabetic obesity onset oral oxidative stress pancreas transplantation pancreatic cancer pancreatic islets pathogenesis pathway patients with diabetes patients with T2DM patients with type periodontal peripheral plasma postprandial prevalence prevention rats receptor reduced renal retinal risk factors role serum Springer Science+Business Media ẞ-cell function studies sulfonylureas symptoms syndrome T1DM T2DM patients target therapy tissue trial type 2 diabetes ulcers vascular viral weight loss


